CN1051236C - Styptic powder - Google Patents
Styptic powder Download PDFInfo
- Publication number
- CN1051236C CN1051236C CN94107005A CN94107005A CN1051236C CN 1051236 C CN1051236 C CN 1051236C CN 94107005 A CN94107005 A CN 94107005A CN 94107005 A CN94107005 A CN 94107005A CN 1051236 C CN1051236 C CN 1051236C
- Authority
- CN
- China
- Prior art keywords
- powder
- ophicalcitum
- present
- radix notoginseng
- bletillae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses blood arresting powder which is a traditional Chinese medicine used for arresting blood. The present invention adopts traditional Chinese medicines of 40 wt% of ophicslcite, 30 wt% of tuber of hyacinth bletilla, 20 wt% of powdered notoginseng and 10 wt% of calamine as raw materials. The ophicslcite and the calamine are respectively calcined by fire, quenched by vinegar, pulverized and ground by water; the tuber of hyacinth bletilla is baked, pulverized and sieved; the materials are uniformly mixed with the powdered notoginseng, and the mixture is disinfected. The present invention has obvious effect of arresting blood and relieving pain on internal wounds and external wounds.
Description
The present invention relates to a kind of hemostatic Chinese medicine drug hemostasis that is used for looses.
Being used for hemostatic Chinese medicine medicine at present on the market is representative with " YUNNAN BAIYAO ", this medicine Chang Sheng since throwing in market does not wane, and its reason is that curative effect is better, portably uses conveniently, be applicable to general wound and a small amount of internal hemorrhage, and not good for the big interior wound result of use of amount of bleeding.
The object of the present invention is to provide a kind of curative effect rapid, the Hemostatic of traditional herb medicine drug hemostasis that is used for large-scale interior wound is loose.
The present invention has selected hemostasis and pain-relieving for use, detumescence and promoting granulation, dissolving blood stasis and detoxication, removing dampness is held back the Chinese medicine medicine of skin ulcer, with the Ophicalcitum is principal agent, with the Pseudobulbus Bletillae (Rhizoma Bletillae) is auxiliary medicine, with the Radix Notoginseng powder is adjuvant drug, is messenger drug with flacourtia rukam stone, earlier with Ophicalcitum, flacourtia rukam stone is forged, quench in vinegar, is ground foam and water flies through fire respectively, again with the Pseudobulbus Bletillae (Rhizoma Bletillae) through drying, porphyrize and sieving, and then select materials and the Radix Notoginseng powder mix homogeneously with above-mentioned, form after sterilization, its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: flacourtia rukam stone=40: 30: 20: 10 again.
The invention has the advantages that it has good local hemostasis effect, can make hemagglutination, form artificial thrombosis, impel the growth and the healing of skin ulcer face granulation tissue.The calcium ion concentration that can promote in the blood for oral administration raises, and makes blood vessel and lymph node densification, prevents that blood plasma from oozing out, and promotes blood coagulation.External can be stopped blooding rapidly, and the molten disconnected and absorption skin ulcer face exudate of energy part has the effect of convergence protection wound, and it is fast to stop blooding, and it is fast to form a scab, and does not infect, and is not afraid of the water logging sweat stain, and has no side effect.
The present invention is further described with embodiment below:
The present invention selects for use Chinese crude drug Ophicalcitum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Notoginseng powder and flacourtia rukam stone as raw material, earlier Ophicalcitum, flacourtia rukam stone are forged, quench in vinegar, ground foam and water flies through fire respectively, again with the Pseudobulbus Bletillae (Rhizoma Bletillae) after drying, grind foam and sieving with 800 purposes sieves, and then select materials and the Radix Notoginseng powder mix homogeneously above-mentioned, again through forming in 1 hour with disinfection by ultraviolet light.Its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: flacourtia rukam stone=40: 30: 20: 10.
Claims (1)
1, a kind of hemostatic Chinese medicine drug hemostasis that is used for is loose, it is characterized in that it is to select for use Chinese medicine medical material Ophicalcitum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Notoginseng powder and flacourtia rukam stone to do raw material, earlier Ophicalcitum, flacourtia rukam stone are forged, quench in vinegar, ground into powder with water and fly through fire respectively, again the Pseudobulbus Bletillae (Rhizoma Bletillae) is sieved through drying, grind into powder and use 800 purposes sieve, and then with above-mentioned select materials with the Radix Notoginseng powder mix homogeneously again after sterilizing and obtain, its part by weight of respectively selecting materials is an Ophicalcitum: the Pseudobulbus Bletillae (Rhizoma Bletillae): Radix Notoginseng powder: flacourtia rukam stone=40: 30: 20: 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94107005A CN1051236C (en) | 1994-06-06 | 1994-06-06 | Styptic powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94107005A CN1051236C (en) | 1994-06-06 | 1994-06-06 | Styptic powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1097622A CN1097622A (en) | 1995-01-25 |
| CN1051236C true CN1051236C (en) | 2000-04-12 |
Family
ID=5032752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94107005A Expired - Fee Related CN1051236C (en) | 1994-06-06 | 1994-06-06 | Styptic powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1051236C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7354570B2 (en) * | 2002-03-08 | 2008-04-08 | Tianjin Kinsly Pharmaceutical R&D Co., Ltd. | Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100453070C (en) * | 2003-12-13 | 2009-01-21 | 昆明紫健生物技术有限公司 | Aseptic dry powder spray agent and production method in use for stopping the blood and diminishing inflammation in wound |
| CN102940854B (en) * | 2012-11-27 | 2014-06-25 | 滨州医学院附属医院 | Traditional Chinese medicine composition for facilitating wound healing after surgical operations, preparation process and application |
| CN102961603A (en) * | 2012-12-07 | 2013-03-13 | 大连创达技术交易市场有限公司 | Hemostatic |
| US20170105915A1 (en) * | 2014-05-20 | 2017-04-20 | Merck Patent Gmbh | Alpha-al2o3 flakes |
| CN105106642A (en) * | 2015-09-09 | 2015-12-02 | 南方医科大学 | Traditional Chinese medicine composition for treating traumatic injuries |
| CN108478721A (en) * | 2018-05-29 | 2018-09-04 | 广州聚澜健康产业研究院有限公司 | A kind of astringing to arrest bleeding frost and preparation method thereof |
-
1994
- 1994-06-06 CN CN94107005A patent/CN1051236C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 《中药大辞典》第一版 1986. 5.30 江苏新医学院编,上海科技出版社出版 * |
| 《中药大辞典》第一版 1986. 5.30 江苏新医学院编,上海科技出版社出版;《陕西中医》1987,8(4) 1987. 3.30 吕兰薰,止血中药的研究动态 * |
| 《陕西中医》1987,8(4) 1987. 3.30 吕兰薰,止血中药的研究动态 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7354570B2 (en) * | 2002-03-08 | 2008-04-08 | Tianjin Kinsly Pharmaceutical R&D Co., Ltd. | Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1097622A (en) | 1995-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101569696A (en) | Chinese medicament for traumatic wound | |
| CN1051236C (en) | Styptic powder | |
| CN104940627A (en) | Traditional Chinese medicine composition for promoting wound healing, and preparation method of traditional Chinese medicine composition | |
| CN104984249A (en) | Composition for treating scalds and preparation method thereof | |
| CN104815172A (en) | Scald ointment as well as preparation method and application method of scald ointment | |
| CN103223077B (en) | Traditional Chinese medicine composition for treating burn and scald | |
| CN106620369A (en) | Hemostatic traditional Chinese medicine powder for external use | |
| CN102028875B (en) | Medicament for treating open wound and preparation method thereof | |
| CN103816247A (en) | External Chinese medicinal composition capable of preventing scarring healing of external injury and preparation method for external Chinese medicinal composition | |
| CN101152290B (en) | Externally used powder preparation stypticum | |
| CN101879254A (en) | Chinese medicinal ointment for treating neonate omphalitis | |
| CN101129678A (en) | Externally used formulated product for treating empyrosis and method of preparing the same | |
| CN103977268A (en) | External injury-healing ointment | |
| CN114848778B (en) | Compound hoop ointment for diminishing inflammation, relieving pain and promoting wound healing as well as preparation method and application thereof | |
| CN104306772A (en) | Traditional Chinese medicine composition for treating radiodermatitis and preparation method of traditional Chinese medicine composition | |
| CN101491626A (en) | Traditional Chinese medicine composition for treating skin injury and suppurative infection | |
| CN105079142A (en) | External hemostatic drug | |
| CN105617273A (en) | Pharmaceutic preparation for promoting wound healing and application thereof | |
| CN117860845A (en) | Prescription of trauma specific medicine and preparation method thereof | |
| CN1103596C (en) | Burn-treating medicine powder and its preparation | |
| CN105079696A (en) | External hemostatic drug | |
| CN104173877A (en) | Traditional Chinese medicine preparation for quick wound healing and preparation method of traditional Chinese medicine preparation for quick wound healing | |
| CN116251153A (en) | External-use pharmaceutical composition for removing acnes and acne marks | |
| CN116983369A (en) | A topical pharmaceutical composition for treating traumatic hemorrhage, and its preparation method | |
| CN105147968A (en) | Traditional Chinese medicinal composition for treating trauma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |